Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹20.7 LQualified | L1 | Qualified MSE, MII, Category: General | |
| 2 | L2₹20.7 L+₹2,250.30 (0.11%)Qualified | L2 | Qualified MSE, MII, Category: General | |
| 3 | L3₹21.0 L+₹34,153.10 (1.65%)Qualified 104 FIRST FLOOR HARI OM COMMERCIAL COMPLEX NEW DAK BUNGLOW ROAD PATNA BIHAR 800001 INDIA | PATNA | BIHAR | 800001 | L3 | Qualified MSE, MII, Category: General | |
| 4 | Qualified NAV BHARAT SCIENTIFIC WORKS BEHIND PUNJAB NATIONAL BANK DILKUSHA MARKET JALANDHAR PUNJAB 144001 UDYAM PB 10 0017282 | JALANDHAR | PUNJAB | 144001 | - | Qualified MSE, MII, Category: General | |
| 5 | Qualified | - | Qualified MII |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
19 Jun 2025, 12:00 pmClosed
ALFUZOSIN 10 MG TAB
CEFIXIME 200 MG TAB
CEFUROXIME 500 MG TAB
COENZYME Q 10 100 MG TAB
COLOSTOMY BAG WITH FLENGE 50MM
DORZOLAMIDE 2 PERCENT W V TIMOLOL 0 POINT 5PERCENT W V ED
DOTHIEPIN 75 MG TAB
ETHAMSYLATE 250MG TAB
GLUCOSAMINE 750 MG AND DIACERINE 50MG TAB
GLUTATHIONE 500 MG TAB
INJ LEVOCARNITINE 500 MG
INJ LIGNOCAINE 2 PERCENT WITH ADRENALINE
LEVOFLOX 500 MG TAB
LEVOSALBUTAMOL 1 POINT 25MG IPRATROPIUM 500MCG RESP
MOXONIDINE 0 POINT 2 MG TAB
MOXONIDINE 0 POINT 3 MG TAB
PARACETAMOL 500MG AND IBUPROFEN 400MG TAB
RIOCIGUAT 0 POINT 5MG TAB
RIPASUDIL 0 POINT 4 PERCENT W V EYE DROPS
SYP ALPHA AMYLASE PEPSIN DIGESTIVE ENZYME
TRIAMCINOLONE 0 POINT 1 PERCENT ORAL PASTE 5 GM TUBE
TRIHEXYPHENIDYL 2MG TAB Bid Number ( ) : GEM/2025/B/6283380 Dated : 29-05-2025 Bid Document 1/21
7898465
GEM/2025/B/6283380
Two Packet Bid
ALFUZOSIN 10 MG TAB
30 days
Gurdaspur, Punjab
Total value wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹3
60%
Exempted
29 May 2025
29 May 2025
19 Jun 2025
MEDICINE DEMAND ECHS RE 15
ALFUZOSIN 10 MG TAB
CEFIXIME 200 MG TAB
CEFUROXIME 500 MG TAB
COENZYME Q 10 100 MG TAB
COLOSTOMY BAG WITH FLENGE 50MM
DORZOLAMIDE 2 PERCENT W V TIMOLOL 0 POINT 5PERCENT W V ED
DOTHIEPIN 75 MG TAB
ETHAMSYLATE 250MG TAB
GLUCOSAMINE 750 MG AND DIACERINE 50MG TAB
GLUTATHIONE 500 MG TAB
INJ LEVOCARNITINE 500 MG
INJ LIGNOCAINE 2 PERCENT WITH ADRENALINE
LEVOFLOX 500 MG TAB
LEVOSALBUTAMOL 1 POINT 25MG IPRATROPIUM 500MCG RESP
MOXONIDINE 0 POINT 2 MG TAB
MOXONIDINE 0 POINT 3 MG TAB
PARACETAMOL 500MG AND IBUPROFEN 400MG TAB
RIOCIGUAT 0 POINT 5MG TAB
RIPASUDIL 0 POINT 4 PERCENT W V EYE DROPS
SYP ALPHA AMYLASE PEPSIN DIGESTIVE ENZYME
TRIAMCINOLONE 0 POINT 1 PERCENT ORAL PASTE 5 GM TUBE
TRIHEXYPHENIDYL 2MG TAB Bid Number ( ) : GEM/2025/B/6283380 Dated : 29-05-2025 Bid Document 1/21
ALFUZOSIN 10 MG TAB
CEFIXIME 200 MG TAB
CEFUROXIME 500 MG TAB
COENZYME Q 10 100 MG TAB
COLOSTOMY BAG WITH FLENGE 50MM
DORZOLAMIDE 2 PERCENT W PER V AND TIMOLOL 0 POINT 5 PERCENT W PER V ED
DOTHIEPIN 75 MG TAB
ETHAMSYLATE 250 MG TAB
GLUCOSAMINE 750 MG AND DIACERINE 50 MG TAB
GLUTATHIONE 500 MG TAB
INJ LEVOCARNITINE 500 MG
INJ LIGNOCAINE 2 PERCENT WITH ADRENALINE
LEVOFLOX 500 MG TAB
LEVOSALBUTAMOL 1 POINT 25MG AND IPRATROPIUM 500MCG RESPULE
MOXONIDINE 0 POINT 2 MG TAB
MOXONIDINE 0 POINT 3 MG TAB
PARACETAMOL 500MG AND IBUPROFEN 400MG TAB
RIOCIGUAT 0 POINT 5MG TAB
RIPASUDIL 0 POINT 4 PERCENT W PER V EYE DROPS
SYP ALPHA AMYLASE PEPSIN DIGESTIVE ENZYME
TRIAMCINOLONE 0 POINT 1 PERCENTAGE ORAL PASTE 5 GM TUBE
TRIHEXYPHENIDYL 2MG TAB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7898465.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
demand_re_15_2025-05-26-13-01-33_43cfa765f46939c9f4aaf3c0d738a257.pdf
BOQ
boq_re_15_2025-05-26-13-01-33_d228618be87876cd79c4c8d0baccdb52.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .